210 related articles for article (PubMed ID: 27989960)
1. A type VII collagen subdomain mutant is thermolabile and shows enhanced proteolytic degradability - Implications for the pathogenesis of recessive dystrophic epidermolysis bullosa?
Windler C; Hermsdorf U; Brinckmann J; Seeger K
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):52-59. PubMed ID: 27989960
[TBL] [Abstract][Full Text] [Related]
2. Chemical shift assignments of the fibronectin III like domains 7-8 of type VII collagen.
Hermsdorf U; Seeger K
Biomol NMR Assign; 2016 Apr; 10(1):53-5. PubMed ID: 26364055
[TBL] [Abstract][Full Text] [Related]
3. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.
Varki R; Sadowski S; Uitto J; Pfendner E
J Med Genet; 2007 Mar; 44(3):181-92. PubMed ID: 16971478
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
Dang N; Murrell DF
Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
[TBL] [Abstract][Full Text] [Related]
5. Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.
Chung HJ; Uitto J
Dermatol Clin; 2010 Jan; 28(1):93-105. PubMed ID: 19945621
[TBL] [Abstract][Full Text] [Related]
6. Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa.
Almaani N; Liu L; Dopping-Hepenstal PJ; Lai-Cheong JE; Wong A; Nanda A; Moss C; Martinéz AE; Mellerio JE; McGrath JA
Acta Derm Venereol; 2011 May; 91(3):262-6. PubMed ID: 21448560
[TBL] [Abstract][Full Text] [Related]
7. Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect.
Nyström A; Buttgereit J; Bader M; Shmidt T; Ozcelik C; Hausser I; Bruckner-Tuderman L; Kern JS
PLoS One; 2013; 8(5):e64243. PubMed ID: 23717576
[TBL] [Abstract][Full Text] [Related]
8. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
[TBL] [Abstract][Full Text] [Related]
9. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.
Dang N; Klingberg S; Marr P; Murrell DF
J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959
[TBL] [Abstract][Full Text] [Related]
10. Type VII collagen is required for Ras-driven human epidermal tumorigenesis.
Ortiz-Urda S; Garcia J; Green CL; Chen L; Lin Q; Veitch DP; Sakai LY; Lee H; Marinkovich MP; Khavari PA
Science; 2005 Mar; 307(5716):1773-6. PubMed ID: 15774758
[TBL] [Abstract][Full Text] [Related]
11. Inversa dystrophic epidermolysis bullosa is caused by missense mutations at specific positions of the collagenic domain of collagen type VII.
Chiaverini C; Charlesworth AV; Youssef M; Cuny JF; Rabia SH; Lacour JP; Meneguzzi G
J Invest Dermatol; 2010 Oct; 130(10):2508-11. PubMed ID: 20555349
[No Abstract] [Full Text] [Related]
12. Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis.
Woodley DT; Hou Y; Martin S; Li W; Chen M
J Biol Chem; 2008 Jun; 283(26):17838-45. PubMed ID: 18450758
[TBL] [Abstract][Full Text] [Related]
13. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
[TBL] [Abstract][Full Text] [Related]
14. Mutation analyses of COL7A1 gene in three Taiwanese patients with severe recessive dystrophic epidermolysis bullosa.
Chao SC; Lee JY
J Formos Med Assoc; 2007 Jan; 106(1):86-91. PubMed ID: 17282977
[TBL] [Abstract][Full Text] [Related]
15. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
[TBL] [Abstract][Full Text] [Related]
16. Characterization of mutant type VII collagens underlying the inversa subtype of recessive dystrophic epidermolysis bullosa.
Woodley DT; Cogan J; Mosallaei D; Yim K; Chen M
J Dermatol Sci; 2021 Nov; 104(2):104-111. PubMed ID: 34674926
[TBL] [Abstract][Full Text] [Related]
17. Late-onset inversa recessive dystrophic epidermolysis bullosa caused by glycine substitutions in collagen type VII.
Leverkus M; Ambach A; Hoefeld-Fegeler M; Kohlhase J; Schmidt E; Schumann H; Has C; Gollnick H
Br J Dermatol; 2011 May; 164(5):1104-6. PubMed ID: 21275939
[TBL] [Abstract][Full Text] [Related]
18. Dystrophic epidermolysis bullosa phenotypes in a large consanguineous Tunisian family.
Ouragini H; Cherif F; Kassar S; Floriddia G; Pascucci M; Daoud W; Osman-Dhahri AB; Boubaker S; Castiglia D; Abdelhak S
J Dermatol Sci; 2009 May; 54(2):114-20. PubMed ID: 19261445
[TBL] [Abstract][Full Text] [Related]
19. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.
Tolar J; Ishida-Yamamoto A; Riddle M; McElmurry RT; Osborn M; Xia L; Lund T; Slattery C; Uitto J; Christiano AM; Wagner JE; Blazar BR
Blood; 2009 Jan; 113(5):1167-74. PubMed ID: 18955559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
